Background: Assessing high-sensitivity C-reactive protein (hs-CRP) in relation to allergic endpoints can shed light on both the mechanisms of allergic disease development and early non-communicable disease prevention. However, only a few epidemiological studies so far have investigated the relationship in children and adolescents, and the results were mixed. Objectives: We sought to examine the interrelation between hs-CRP levels and allergic outcomes using a larger population size and a longitudinal study design. Methods: Complete data were available on 1,955 participants from the 15-years follow-up of the 2 large population-based German birth cohorts – GINIplus and LISA. Serum hs-CRP concentrations were measured using the immunoturbidimetric high-sensitive assay. Six allergic endpoints were used – doctor-diagnosed asthma, doctor-diagnosed eczema, doctor-diagnosed allergic rhinitis, food sensitization, aeroallergen sensitization, and any sensitization. We used generalized estimation equation models to assess the associations between hs-CRP levels and allergic endpoints. Results: Our longitudinal analyses did not detect any significant association between hs-CRP levels and any of the studied allergic outcomes (e.g., asthma, eczema, allergic rhinitis, food sensitization, aeroallergen sensitization, and any sensitization). The results were consistent in a series of sensitivity analyses. Conclusions: Our study suggests that there is no association between hs-CRP levels and any of the allergic endpoints in German adolescents. However, whether allergic diseases are inflammatory conditions and which markers might be most sensitive, remain to be confirmed in future studies.

1.
Strachan
DP
.
Hay fever, hygiene, and household size
.
BMJ
.
1989
Nov
;
299
(
6710
):
1259
60
.
[PubMed]
0959-8138
2.
Prescott
SL
.
Early-life environmental determinants of allergic diseases and the wider pandemic of inflammatory noncommunicable diseases
.
J Allergy Clin Immunol
.
2013
Jan
;
131
(
1
):
23
30
.
[PubMed]
0091-6749
3.
Livnat
G
,
Yoseph
RB
,
Nir
V
,
Hakim
F
,
Yigla
M
,
Bentur
L
.
Evaluation of high-sensitivity serum CRP levels compared to markers of airway inflammation and allergy as predictors of methacholine bronchial hyper-responsiveness in children
.
Lung
.
2015
Feb
;
193
(
1
):
39
45
.
[PubMed]
0341-2040
4.
Mustonen
K
,
Keski-Nisula
L
,
Vaarala
O
,
Pfefferle
PI
,
Renz
H
,
Riedler
J
, et al.;
PASTURE Study Group
.
Few associations between high-sensitivity C-reactive protein and environmental factors in 4.5-year-old children
.
Pediatr Allergy Immunol
.
2012
Sep
;
23
(
6
):
522
8
.
[PubMed]
0905-6157
5.
Mustonen
K
,
Orivuori
L
,
Keski-Nisula
L
,
Hyvärinen
A
,
Pfefferle
PI
,
Riedler
J
, et al.;
PASTURE Study Group
.
Inflammatory response and IgE sensitization at early age
.
Pediatr Allergy Immunol
.
2013
Jun
;
24
(
4
):
395
401
.
[PubMed]
0905-6157
6.
Chawes
BL
,
Stokholm
J
,
Schoos
AM
,
Fink
NR
,
Brix
S
,
Bisgaard
H
.
Allergic sensitization at school age is a systemic low-grade inflammatory disorder
.
Allergy
.
2017
Jul
;
72
(
7
):
1073
80
.
[PubMed]
0105-4538
7.
Visness
CM
,
London
SJ
,
Daniels
JL
,
Kaufman
JS
,
Yeatts
KB
,
Siega-Riz
AM
, et al.
Association of obesity with IgE levels and allergy symptoms in children and adolescents: results from the National Health and Nutrition Examination Survey 2005-2006
.
J Allergy Clin Immunol
.
2009
May
;
123
(
5
):
1163
9
.
[PubMed]
0091-6749
8.
Berg
A
,
Krämer
U
,
Link
E
,
Bollrath
C
,
Heinrich
J
,
Brockow
I
, et al.;
GINIplus study group
.
Impact of early feeding on childhood eczema: development after nutritional intervention compared with the natural course - the GINIplus study up to the age of 6 years
.
Clin Exp Allergy
.
2010
Apr
;
40
(
4
):
627
36
.
[PubMed]
0954-7894
9.
Zutavern
A
,
Brockow
I
,
Schaaf
B
,
Bolte
G
,
von Berg
A
,
Diez
U
, et al.;
LISA Study Group
.
Timing of solid food introduction in relation to atopic dermatitis and atopic sensitization: results from a prospective birth cohort study
.
Pediatrics
.
2006
Feb
;
117
(
2
):
401
11
.
[PubMed]
0031-4005
10.
Harris
C
,
Demmelmair
H
,
von Berg
A
,
Lehmann
I
,
Flexeder
C
,
Koletzko
B
, et al.
Associations between fatty acids and low-grade inflammation in children from the LISAplus birth cohort study
.
Eur J Clin Nutr
.
2017
Nov
;
71
(
11
):
1303
11
.
[PubMed]
0954-3007
11.
Lødrup Carlsen
KC
,
Håland
G
,
Devulapalli
CS
,
Munthe-Kaas
M
,
Pettersen
M
,
Granum
B
, et al.
Asthma in every fifth child in Oslo, Norway: a 10-year follow up of a birth cohort study
.
Allergy
.
2006
Apr
;
61
(
4
):
454
60
.
[PubMed]
0105-4538
12.
Markevych
I
,
Baumbach
C
,
Standl
M
,
Koletzko
S
,
Lehmann
I
,
Bauer
CP
, et al.
Early life travelling does not increase risk of atopic outcomes until 15 years: results from GINIplus and LISAplus
.
Clin Exp Allergy
.
2017
Mar
;
47
(
3
):
395
400
.
[PubMed]
0954-7894
13.
Liang
KY
,
Zeger
SL
.
Longitudinal data analysis using generalized linear models
.
Biometrika
.
1986
;
73
(
1
):
13
22
. 0006-3444
14.
R Core Team
. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing:
2012
. Available at: http://www.R-project.org/
15.
Højsgaard
S
,
Halekoh
U
,
Yan
J
.
The R Package geepack for generalized estimation equations
.
J Stat Softw
.
2006
;
15
:
1
11
.1548-7660
16.
Penders
J
,
Stobberingh
EE
,
van den Brandt
PA
,
Thijs
C
.
The role of the intestinal microbiota in the development of atopic disorders
.
Allergy
.
2007
Nov
;
62
(
11
):
1223
36
.
[PubMed]
0105-4538
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.